|
C13ORF31 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.53580547857769E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30500063480577E-11 |
| Normal-vs-Stage2 |
8.848800E-04 |
| Normal-vs-Stage3 |
1.94510000000037E-05 |
| Normal-vs-Stage4 |
2.429800E-02 |
| Stage1-vs-Stage2 |
4.723000E-01 |
| Stage1-vs-Stage3 |
1.801010E-01 |
| Stage1-vs-Stage4 |
3.777800E-03 |
| Stage2-vs-Stage3 |
1.936420E-01 |
| Stage2-vs-Stage4 |
3.315700E-02 |
| Stage3-vs-Stage4 |
1.184370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.94010412974444E-11 |
| Normal-vs-AfricanAmerican |
9.644500E-03 |
| Normal-vs-Asian |
6.084100E-02 |
| Caucasian-vs-AfricanAmerican |
6.829900E-02 |
| Caucasian-vs-Asian |
5.877400E-01 |
| AfricanAmerican-vs-Asian |
1.783790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32029998045624E-09 |
| Normal-vs-Female |
3.90219999646391E-08 |
| Male-vs-Female |
9.999400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.571700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.34980004951046E-09 |
| Normal-vs-Age(61-80Yrs) |
7.11490000249171E-08 |
| Normal-vs-Age(81-100Yrs) |
9.237000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.480420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.412000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.563200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.954500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.871800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.987600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.978200E-03 |
| Normal-vs-Grade 2 |
3.96270016800315E-10 |
| Normal-vs-Grade 3 |
4.12299999696941E-08 |
| Normal-vs-Grade 4 |
8.261200E-03 |
| Grade 1-vs-Grade 2 |
5.829800E-01 |
| Grade 1-vs-Grade 3 |
1.962640E-01 |
| Grade 1-vs-Grade 4 |
1.111030E-01 |
| Grade 2-vs-Grade 3 |
1.472040E-01 |
| Grade 2-vs-Grade 4 |
5.600500E-02 |
| Grade 3-vs-Grade 4 |
2.498400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.38986608280811E-12 |
| Normal-vs-ccB subtype |
3.50510000002302E-06 |
| ccA subtype-vs-ccB subtype |
6.839300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.46459999578386E-08 |
| Normal-vs-N1 |
1.164780E-01 |
| N0-vs-N1 |
5.794400E-01 |
|
|
